Table 6.
No. | Mol. formula | Mol. weight | Aspect | 1H-NMR | 13C-NMR | Systematic Name | Reference |
---|---|---|---|---|---|---|---|
1 | C30H50O3 | 458.72 | Amorphous powder | CDCl3 | CDCl3 | Olean-12-ene-3β,16β,28-triol | [81,82,83] |
- | C5D5N | [93] | |||||
2 | C30H50O4 | 474.72 | Amorphous powder | C5D5N | C5D5N | Olean-12-ene-3β,16β,22α,28-tetrol | [81,82] |
3 | C30H50O4 | 474.72 | Amorphous powder | C5D5N | C5D5N | Olean-12-ene-3β,16β,21β,28-tetrol | [81,83] |
4 | C30H48O6 | 504.70 | White amorphous powder | C5D5N | C5D5N | Olean-12-en-30-oic acid, 3,16,22,28-tetrahydroxy-, (3β,16β,20β,22β) a | [88] |
5 | C36H58O9 | 834.84 | Amorphous powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β)-16,28-dihydroxyolean-12-en-3-yl | [89] |
6 | C43H62O11 | 754.95 | Amorphous powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,21β)-21-benzoyloxy-16,28-dihydroxyolean-12-en-3-yl | [89] |
7 | C36H56O11 | 664.82 | N. a. | N. a. | N. a. | β-d-Glucopyranosiduronic acid, (3β,16β,20α)-20-carboxy-16,28-dihydroxy-30-norolean-12-en-3-yl | [103] |
8 | C37H60O10 | 664.87 | White powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,21β)-16,21,28-trihydroxyolean-12-en-3-yl, methyl ester | [91] |
9 | C42H68O14K | 836.08 | Amorphous powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β)-16,28-dihydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl-, monopotassium salt | [92] |
10 | C42H68O15 | 812.98 | Colorless needles | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,22α)-16,22,28-trihydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl | [93] |
11 | C49H72O16 | 917.09 | Amorphous powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,21β)-21-benzoyloxy-16,28-dihydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl | [92] |
12 | C42H68O15K | 852.08 | Amorphous powder | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,20α)-16,28,29-trihydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl-, monopotassium salt | [92] |
13 | C48H80O18 | 945.14 | White powder | C5D5N | C5D5N | β-d-Glucopyranoside, (3β,16β)-28-β-d-glucopyranosyloxy-16-hydroxyolean-12-en-3-yl 6-O-β-d-glucopyranosyl | [91] |
14 | C53H88O22 | 1077.25 | Colorless needles | C5D5N | C5D5N | β-d-Glucopyranoside, (3β,16β)-28-β-d-glucopyranosyloxy-16-hydroxyolean-12-en-3-yl 6-[β-d-xylopyranosyl-(1→6)-O-β-d-glucopyranosyl] | [94] |
15 | C48H80O17 | 929.14 | White amorphous powder | N. a. | N. a. | 6-Deoxy-α-l-Rhamnopyranoside, (3β,16β,22α)-16-(hydroxy)-28-[(6-deoxy-α-L-mannopyranosyl)oxy]-22-hydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl | [95] |
16 | C50H80O20 | 1001.16 | Colorless needles | C5D5N | C5D5N | β-d-Glucopyranosiduronic acid, (3β,16β,22α)-16-acetyloxy-28-[(6-deoxy-α-L-mannopyranosyl)oxy]-22-hydroxyolean-12-en-3-yl 3-O-β-d-glucopyranosyl | [92,93] |
a There is no correspondence between the structure and name of the compound reported in the literature and as indicated by the CAS number; N. a. = Not available.